STAAR Surgical Company STAA
NASDAQ
| 07/03/2026 | 04/03/2026 | 01/02/2026 | 09/26/2025 | 06/27/2025 | |
|---|---|---|---|---|---|
| Revenue | 339.59M | 290.38M | 239.44M | 230.59M | 224.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 339.59M | 290.38M | 239.44M | 230.59M | 224.45M |
| Cost of Revenue | 79.39M | 67.10M | 57.02M | 60.26M | 63.51M |
| Gross Profit | 260.20M | 223.27M | 182.42M | 170.33M | 160.94M |
| SG&A Expenses | 180.62M | 178.21M | 188.10M | 192.43M | 198.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 298.33M | 283.95M | 285.18M | 293.27M | 305.88M |
| Operating Income | 41.26M | 6.42M | -45.74M | -62.68M | -81.43M |
| Income Before Tax | 17.38M | -19.56M | -82.26M | -91.95M | -97.58M |
| Income Tax Expenses | 13.54M | 1.47M | -1.82M | 4.42M | -2.31M |
| Earnings from Continuing Operations | 3.84 | -21.03 | -80.45 | -96.37 | -95.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.84M | -21.03M | -80.45M | -96.37M | -95.27M |
| EBIT | 41.26M | 6.42M | -45.74M | -62.68M | -81.43M |
| EBITDA | 49.76M | 14.51M | -37.42M | -53.99M | -72.99M |
| EPS Basic | 0.08 | -0.42 | -1.63 | -1.95 | -1.93 |
| Normalized Basic EPS | 0.56 | 0.16 | -0.46 | -0.74 | -0.88 |
| EPS Diluted | 0.07 | -0.43 | -1.63 | -1.96 | -1.93 |
| Normalized Diluted EPS | 0.55 | 0.15 | -0.47 | -0.74 | -0.88 |
| Average Basic Shares Outstanding | 199.62M | 198.82M | 198.26M | 197.76M | 197.33M |
| Average Diluted Shares Outstanding | 202.71M | 200.73M | 199.17M | 198.68M | 197.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |